Preparation and pharmaceutical properties of Hangeshashinto oral ointment and its safety and efficacy in Syrian hamsters with 5-fluorouracil-induced oral mucositis
Open Access
- 24 August 2022
- journal article
- research article
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 77 (1) , 53-63
Abstract
Chemotherapy-induced oral mucositis (COM) is a common adverse effect of cancer chemotherapy. Several clinical studies reported that repetitive use of mouthwashes containing 2.5–6.25% Hangeshashinto (HST), a Kampo formula, relieves COM, but the effect is insufficient. To solve this problem, we produced an oral ointment of 12% HST extract (considered quantitatively equivalent to 20% commercially available HST), which will increase the local concentrations of its active ingredients and prolong the contact time with COM. In this study, we evaluated the pharmaceutical properties (spreadability and stability) of HST oral ointment. In addition, its safety (oral mucosal irritation) and therapeutic effects on 5-fluorouracil-induced oral mucositis were evaluated in male Syrian hamsters. The HST ointment showed good spreadability and stability for more than 8 weeks at 4 °C. In the oral mucosal irritation test, topical application of HST ointment (0.2 g) three times per day for 14 days had no adverse effect on the oral mucosa of hamsters. In hamsters treated with 5-fluorouracil (60 mg/kg) twice, COM was induced by a submucosal injection of 5% acetic acid into the cheek pouch. When HST ointment (50 µg) was topically applied to the mucositis area once per day for 12 days, the area and macroscopic score of mucositis were significantly decreased, and the depth of the wound tended to be reduced compared with the lactose ointment-treated control animals. These findings suggest that HST oral ointment shows good properties in spreadability, stability, and safety, and elicits a therapeutic effect in an animal model of COM. Graphical abstractKeywords
Funding Information
- Japan Society for the Promotion of Science (20H03390, 20H05506)
This publication has 31 references indexed in Scilit:
- A traditional Japanese medicine—Hangeshashinto (TJ-14)—alleviates chemoradiation-induced mucositis and improves rates of treatment completionSupportive Care in Cancer, 2014
- Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositisCancer Chemotherapy and Pharmacology, 2014
- Multitargeted Effects of Hangeshashinto for Treatment of Chemotherapy-Induced Oral Mucositis on Inducible Prostaglandin E2 Production in Human Oral KeratinocytesIntegrative Cancer Therapies, 2014
- Alteration of the Redox State with Reactive Oxygen Species for 5-Fluorouracil-Induced Oral Mucositis in HamstersPLOS ONE, 2013
- Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patientsSupportive Care in Cancer, 2013
- Effects of the tumour necrosis factor‐α inhibitors pentoxifylline and thalidomide in short‐term experimental oral mucositis in hamstersEuropean Journal of Oral Sciences, 2005
- The burdens of cancer therapyCancer, 2003
- Preparation and Clinical Application of 2% Diflunisal Oral Ointment for Painful Lesions of the Oral MucosaYAKUGAKU ZASSHI, 2001
- Simultaneous Determination of Baicalin, Wogonoside, Baicalein, Wogonin, Berberine, Coptisine, Palmatine, Jateorrhizine and Glycyrrhizin in Kampo Medicines by Ion-Pair High-Performance Liquid Chromatography.Biological and Pharmaceutical Bulletin, 1999
- High-performance liquid chromatographic assay for prostaglandin E1 in various ointment vehiclesJournal of Chromatography A, 1984